About
Antibody-drug Conjugate
Areas of Focus
Categories
Biologics & BiopharmaceuticalSmall Molecule PharmaceuticalAntibodySan Diego & Southern California
Clinical Trials (4)
View allTotal Trials
4
As Lead Sponsor
2
As Collaborator
2
Total Enrollment
168
By Phase
PHASE1: 3PHASE1/PHASE2: 1
By Status
COMPLETED: 2RECRUITING: 1ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
Today
Hover over trial bars to see details
Recent Trials
NCT05245006Collaborator
PET Imaging Study of 89Zr-DFO-YS5 in Men With Prostate Cancer
PHASE1Recruiting
37 participants
Started: Mar 18, 2022 · Completed: Dec 31, 2025
NCT05011188Collaborator
FOR46 in Combination With Enzalutamide in Patients With Metastatic Castration Resistant Prostate Cancer
PHASE1/PHASE2Active, not recruiting
44 participants
Started: Jan 19, 2022 · Completed: Jul 31, 2027
NCT03650491Lead Sponsor
A Study of FOR46 in Patients With Relapsed or Refractory Multiple Myeloma (RRMM)
PHASE1Completed
31 participants
Started: Apr 3, 2019 · Completed: Jan 31, 2022
NCT03575819Lead Sponsor
A Phase 1 Study of FOR46 in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
PHASE1Completed
56 participants
Started: Feb 4, 2019 · Completed: Nov 22, 2023
Locations (1)
Headquarters
La Jolla, CA, United States
Map
Loading map...